To test the impact of inhibiting Y211 phosphorylation of PCNA in breast cancer cell growth, MDA-MB-231 (Fig. 3A) and BT474 (Fig. 3B) cells were treated with the Y211F peptide or the control peptide. Here, PCNA is linked to breast carcinoma.